Literature DB >> 18167163

Transfusion support for a patient with McLeod phenotype without chronic granulomatous disease and with antibodies to Kx and Km.

I Bansal1, H-R Jeon, S R Hui, B W Calhoun, D W Manning, T J Kelly, S Lee, B W Baron.   

Abstract

BACKGROUND AND OBJECTIVES: Kell antigens are encoded by the KEL gene on the long arm of chromosome 7. Kx antigen is encoded by the XK gene on the short arm of the X chromosome. Kell and Kx proteins in the red cell membrane are covalently linked by a disulphide bond. The McLeod phenotype is characterized by weakened expression of antigens in the Kell blood group system, absence of Km and Kx antigens, and acanthocytosis. It has an X-linked mode of inheritance with transmission through carrier females. Some males with the McLeod syndrome also have chronic granulomatous disease (CGD). It is generally believed that patients with non-CGD McLeod may develop anti-Km but not anti-Kx, but that those with CGD McLeod can develop both anti-Km and anti-Kx.
MATERIALS AND METHODS: We present serological data, DNA genotyping and gene sequencing, monocyte monolayer assay and neutrophil oxidative burst test from a patient with the McLeod phenotype without clinical evidence of CGD.
RESULTS: We report here the second example of a patient with non-CGD McLeod who developed anti-Kx in addition to anti-Km. Sequencing of our patient's XK gene confirmed the presence of a mutation resulting in a premature stop codon and lack of Kx protein in the red cell membrane, which is consistent with the diagnosis of McLeod syndrome. Neutrophil oxidative burst test was normal, indicating that our patient did not have CGD. The challenge of providing 10 compatible blood units for multiple surgeries was met.
CONCLUSION: The second case of a rare entity, a patient with non-CGD McLeod who developed anti-Kx and anti-Km, was managed successfully with a combination of autologous donations and procurement of compatible units from national and international sources.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18167163     DOI: 10.1111/j.1423-0410.2007.01021.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  5 in total

1.  Molecular Basis of KELnull Phenotype in Brazilians.

Authors:  Edmir Boturão-Neto; Mihoko Yamamoto; Akemi Kuroda Chiba; Elisa Yuriko Sugano Kimura; Maria do Carmo Valgueiro Costa de Oliveira; Cláudia Lumack do Monte Barretto; Mércia Maria Alves Nunes; Sérgio Roberto Lopes Albuquerque; Marcos Daniel de Deus Santos; José Orlando Bordin
Journal:  Transfus Med Hemother       Date:  2014-12-19       Impact factor: 3.747

2.  Successful hematopoietic stem-cell transplantation in a patient with chronic granulomatous disease and McLeod phenotype sensitized to Kx and K antigens.

Authors:  M Hönig; W A Flegel; K Schwarz; J F Freihorst; U Baumann; A Seltsam; K-M Debatin; A S Schulz; W Friedrich
Journal:  Bone Marrow Transplant       Date:  2009-06-08       Impact factor: 5.483

Review 3.  Untangling the Thorns: Advances in the Neuroacanthocytosis Syndromes.

Authors:  Ruth H Walker
Journal:  J Mov Disord       Date:  2015-05-31

Review 4.  Management of Neuroacanthocytosis Syndromes.

Authors:  Ruth H Walker
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2015-10-19

5.  A patient with McLeod syndrome showing involvement of the central sensorimotor tracts for the legs.

Authors:  Takenobu Murakami; Dan Abe; Hideyuki Matsumoto; Ryo Tokimura; Mitsunari Abe; Amanda Tiksnadi; Shunsuke Kobayashi; Chikako Kaneko; Yuka Urata; Masayuki Nakamura; Akira Sano; Yoshikazu Ugawa
Journal:  BMC Neurol       Date:  2019-11-27       Impact factor: 2.474

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.